PMV PHARMACEUTICALS INC
PMVPNASDAQ🏆 #3255 by market capUS Equity
$742.68▼ $21.09 (−2.84%)
Simulated price1h—
24h▼ 2.8%
7d▲ 63106.8%
14d▲ 69964.2%
30d▲ 57472.1%
1y▲ 50768.5%
🏦Market Cap
$66M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
49
Weak
Trading Snapshot
- Day Range
- $732.64 – $747.36
- 52-Week Range
- $1.02 – $1.88
- Volume
- $2.73B
- Avg Volume
- $2.21B
- Shares Outstanding
- 53.3M
- Next Earnings
- Oct 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $9M
- Last Q Revenue
- $2M
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- $-1.48
- Dividend Yield
- —
Why Investors Own PMVP
- ✓High-growth profile — revenue up +28.7% YoY with expanding US Equity exposure.
- ✓Healthy economics — 43% gross margin and 8% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$9M▲ +22.4% YoY
Gross Margin (TTM)
42.9%▲ +0.9% YoY
Operating Income (TTM)
$960,873▲ +22.4% YoY
Free Cash Flow (TTM)
$692,937▲ +22.4% YoY
About PMV PHARMACEUTICALS INC
A company profile for PMV PHARMACEUTICALS INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
49/100
Analyst Price Target
ⓘAverage Target
$726.48
▼ −2.2% Downside
High Target$849.53
Low Target$583.19
Based on 33 analysts
Latest News & Updates
🚀
Bloomberg·2h ago
PMV PHARMACEUTICALS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Reuters·5h ago
Analysts lift PMVP price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Barron’s·1d ago
PMV PHARMACEUTICALS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.